Post hoc analysis of epicutaneous immunotherapy for peanut allergy phase 3 results: Relevance for exposure through restaurant meals

Ann Allergy Asthma Immunol. 2021 Feb;126(2):208-209. doi: 10.1016/j.anai.2020.11.015. Epub 2020 Nov 28.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens
  • Arachis
  • Child
  • Child, Preschool
  • Desensitization, Immunologic / methods*
  • Dietary Exposure*
  • Double-Blind Method
  • Humans
  • Peanut Hypersensitivity / therapy*
  • Restaurants*

Substances

  • Allergens

Associated data

  • ClinicalTrials.gov/NCT02636699